Redefining Expectations in Rare Disease About Amicus Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Learn More About BioMarin We are guided by people living with rare diseases across the globe.
Claim this company profile
Please sign in to claim this profile.
Company reviews
No approved reviews yet.
Please sign in to write a review. One review per account and company.